Page last updated: 2024-08-26

arginyl-glycyl-aspartic acid and 2-(4-isothiocyanatobenzyl)-1,4,7-triazacyclononane-1,4,7-triacetic acid

arginyl-glycyl-aspartic acid has been researched along with 2-(4-isothiocyanatobenzyl)-1,4,7-triazacyclononane-1,4,7-triacetic acid in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, YS; Cheon, GJ; Chung, JK; Hong, MK; Jeong, JM; Kim, YJ; Lee, DS; Lee, MC; Lee, YS1

Other Studies

1 other study(ies) available for arginyl-glycyl-aspartic acid and 2-(4-isothiocyanatobenzyl)-1,4,7-triazacyclononane-1,4,7-triacetic acid

ArticleYear
Preparation of a promising angiogenesis PET imaging agent: 68Ga-labeled c(RGDyK)-isothiocyanatobenzyl-1,4,7-triazacyclononane-1,4,7-triacetic acid and feasibility studies in mice.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2008, Volume: 49, Issue:5

    Topics: Animals; Coordination Complexes; Feasibility Studies; Gallium Radioisotopes; Heterocyclic Compounds; Hindlimb; Humans; Hypoxia; Ischemia; Isothiocyanates; Male; Mice; Neovascularization, Pathologic; Oligopeptides; Positron-Emission Tomography; Staining and Labeling; Transplantation, Heterologous

2008